Skip to main content
Figure 4 | BMC Neurology

Figure 4

From: Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS

Figure 4

CART analyses using all 34 single biomarker candidate proteins. CART was analyzed for 34 single biomarker candidate proteins identified in the CSF under each pH condition (pH 5, 7 and 9) to discriminate patients with MMD from control patients. This analysis correctly classified 19 of 20 patients with MMD and all 12 control patients based on the peak intensities of the m/z 4473 peak (pH 5) and m/z 4588 peak (pH 7).

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us